Medical References
Proven, effective, and drug-free
Allen Carr’s Easyway is a proven, effective, drug-free alternative to nicotine patches, nicotine gum and e-cigarettes, potentially taking the treatment of smokers out of the hands of Big Tobacco & Big Pharma.
RCTs Prove Easyway Effectiveness
A fully independent Randomized Control Trial (RCT), conducted on behalf of the Irish Government, has found that it is twice as effective as the techniques currently offered by the Irish Health Service (which include nicotine patches, e-cigarettes and gum). The trial results have been reported in the BMJ’s Tobacco Control Journal on 26 October 2018, which can be found here:
John Dicey, Global CEO of Allen Carr’s Easyway comments:
“This is a landmark day as, for the first time, it presents the results of the program’s performance in a robust clinical trial. There is no doubt that being a cognitive (spoken) method doesn’t make it particularly suitable for this kind of clinical trial but even in these circumstances we’re delighted that the method was found to be twice effective as the current treatments available in Ireland. We are also expecting the findings of a London-based RCT to be published soon, which should confirm that Allen Carr’s Easyway method is better than, or at least as good as, the current gold standard One-to-One NHS Stop Smoking Service. This should pave the way for this drug-free, quick & easy method to be made available via the Irish Health Service and the NHS.”
The results of the trial show that Allen Carr’s Easyway quit rates were ALWAYS superior to Quit.ie, consistently achieving higher quit rates at 1, 3, 6 and 12 months.
Natalie Clays, Managing Director of Allen Carr’s Easyway USA said:
“These results should give the US Government the confidence to make Allen Carr’s Easyway to Stop Smoking Seminar program available as an exciting alternative to nicotine patches, nicotine gum, and other publicly funded treatments in America. Working together, we can now provide a realistic and more cost-effective opportunity to free Americans of smoking – which was the reason that the Irish Government’s Minister for Health pushed so strongly for the study to happen.”
Professor Luke Clancy, a founder and director general of The Tobacco Free Research Institute Ireland, said that the results mean he can now tell patients to use the Allen Carr method.
“After this trial, I can now recommend Allen Carr treatment and can recommend it to the government if they ask for advice.”
It is believed that this is the first time that such a therapy has been subjected to the rigors of a full RCT.
Allen Carr’s Easyway to Stop Smoking Seminar Program does not rely on any nicotine, nicotine substances, patches or other pharmaceuticals. It challenges the reasons why people smoke, and most people report that they not only stop smoking, but actually lose the desire to smoke.
John Dicey continues:
“Adding our program to their menu of services would not only save hundreds and thousands more lives but also save the public health system millions of dollars a year. While many health bodies continue to promote the use of NRT, Chantix, Zyban and e-cigarettes, it’s surely essential that they also provide an alternative which is 100% safe, drug-free and proven – especially one that would excite and encourage smokers to seek assistance to quit. Allen Carr’s Easyway organization is even prepared to offer its famous money back guarantee to the public health service.
With smoking cessation medications currently costing the government around $50million per year and the social and economic cost estimated at $31.5 billion a year, we are confident that introducing our method will make a major impact to success rates and cost savings for the health service.”
Further Medical References
UK Clinical Trial finds Allen Carr’s Easyway as good as, if not better than, the Gold Standard NHS Programme which uses NRT & 1-1 psychological support.
Frings D, Albery IP, Moss AC, Brunger H, Burghelea M, White S, and Wood KV (2020) Comparison of Allen Carr’s Easyway programme with a specialist behavioural and pharmacological smoking cessation support service: a randomized controlled trial. Addiction 115: doi: 10.1111/add.14897
National 12 month Clinical Trial finds Allen Carr’s Easyway almost twice as effective as other smoking cessation methods available on Health Service.
Keogan, S., Li, S., Clancy L. (2018) Allen Carr’s Easyway to Stop Smoking – A randomised clinical trial. BMJ Tobacco Control, Issue 4 Volume 28
After a 3 year study 51% reported continuing abstinence.
Moshammer, H., & Neuberger, M. (2007). Long term success of short smoking cessation seminars supported by occupational health care. Addictive Behaviors, 32(7), 1486-1493
Smokers following Allen Carr’s Easyway were about 6 times more likely to be abstinent, assessed after 13 months, compared to similar smokers in the general population.
Dijkstra, A., Zuidema, R., Vos, D., Van Kalken, M., The effectiveness of the Allen Carr smoking cessation training in companies tested in a quasi-experimental design. BMC Public Health volume 14, Article number: 952 (2014)
The 1 year quit rate was 55%. A long smoking history or many earlier unsuccessful attempts to quit did not predict failure.
Hutter, H., Moshammer, H. & Neuberger, M. Int Arch Occup Environ Health (2006) 79: 42
NICE guidance on treating tobacco dependence says that the Easyway in-person group seminar should be available through the NHS for adults who smoke. Evidence shows it is cost effective and value for money for the NHS.
Tobacco: preventing uptake, promoting quitting and treating dependence. NICE guideline [NG209]
The 2 year quit rate was 37.5% and reduced absenteeism of 85%
Di Prinzio, Bondanini, De Falco, Vinci, Camisa, Santoro, Arnesano, Dalmasso, Raponi, Di Brino, Cicchetti, Magnavita, Zaffina. Feasibility of a Stop Smoking Program for Healthcare Workers in an Italian Hospital: Econometric Analysis in a Total Worker Health® Approach. Annals of Global Health (2023) Vol: 89 Issue 1
